MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Amyotrophic Lateral Sclerosis Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,374 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,374 works in the cohort · of 4,299,418page 22 of 48

Labels cover 4 of 2,374 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,374 of 2,374 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
The prion-like nature of amyotrophic lateral sclerosis
Luke McAlary, Justin J. Yerbury, Neil R. Cashman
2020· review· en· Progress in molecular biology and translational science· Medicine
machine prediction:candidate · noneconsensus · none
21
citations
affno abstractunlabeled
Amyotrophic lateral sclerosis
Bart M. Demaerschalk, Michael J. Strong
2000· article· en· Current Treatment Options in Neurology· Medicine
machine prediction:candidate · noneconsensus · none
19
citations
affunlabeled
TDP-43 loss induces cryptic polyadenylation in ALS/FTD
Sam Bryce-Smith, Anna‐Leigh Brown, Max Z. Y. J. Chien, Dario Dattilo, Puja R. Mehta, Francesca Mattedi +103 more
2025· article· en· Nature Neuroscience· Medicine
machine prediction:candidate · noneconsensus · none
19
citations
afffundunlabeled
Matrin3: Disorder and ALS Pathogenesis
Ahmed Salem, Carter J. Wilson, Benjamin S. Rutledge, Allison A. Dilliott, Sali M.K. Farhan, Wing‐Yiu Choy +1 more
2022· review· en· Frontiers in Molecular Biosciences· Medicine
machine prediction:candidate · noneconsensus · none
18
citations
affunlabeled
Riluzole in Spinal Cord Injury Study (RISCIS)–Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial
Diana Shu-Lian Chow, Ashley Nguyen, Junghwa Park, Lei Wu, Elizabeth G. Toups, James S. Harrop +6 more
2023· article· en· Journal of Neurotrauma· Medicine
machine prediction:candidate · noneconsensus · none
18
citations
afffundno abstractunlabeled
Oligogenicity, C9orf72 expansion, and variant severity in ALS
Jay P. Ross, Claire S. Leblond, Sandra B. Laurent, Dan Spiegelman, Alexandre Dionne‐Laporte, William Camu +3 more
2020· article· de· Neurogenetics· Medicine
machine prediction:candidate · noneconsensus · none
18
citations

How this was built: Screen · Findings · About